Core Viewpoint - Sampo plc has initiated a share buyback program with a maximum value of EUR 200 million, which commenced on 7 August 2025, following the authorization from its Annual General Meeting on 23 April 2025 [1][2]. Group 1: Share Buyback Details - On 20 August 2025, Sampo plc acquired a total of 323,763 A shares at a daily weighted average price of EUR 9.96 [1]. - The buyback transactions were executed across multiple markets, including AQEU, CEUX, TQEX, and XHEL, with respective volumes of 7,235, 125,148, 34,713, and 156,667 shares [1]. - The total number of Sampo A shares owned by the company after the transactions is 3,275,016, representing 0.12% of the total shares outstanding [2].

Espoo, Finland, 21 August 2025: Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop Parkinson’s disease, releases today the Company’s 1H 2025 report. The full report is available at the Company’s website: www.herantis.com. Antti Vuolanto, CEO of Herantis, said: “We made significant clinical progress in the first half of 2025, advancing HER-096 through the Phase 1b study which is now approaching completion on schedule, a key milestone. We reported encoura ...

Core Insights - VGP NV reported a pre-tax profit of €208.6 million for H1 2025, marking a 35% increase compared to H1 2024, driven by net rental income and valuation gains [2] - The company achieved a total committed annualized rental income of €441.3 million, reflecting a 7% year-to-date increase and 14.7% organic growth year-over-year [2] - VGP's total investment property at share increased by 8.3% to €5.4 billion, with a balance sheet total surpassing €5 billion [2] Financial Performance - Net rental and renewable energy income rose by 24.3% to €40.9 million, while joint venture management fee income increased by 2.6% to €16.1 million [2] - Net valuation gains on the portfolio reached €141.5 million, representing a 42.8% increase [2] - On a look-through basis, net rental income increased by 16.4% compared to H1 2024, totaling €103.9 million [2] Leasing and Development - VGP signed and renewed lease agreements totaling €56.1 million, covering 822,000 sqm during H1 2025 [2] - The pre-let ratio for assets under construction is currently at 76%, with projects older than six months achieving an 80% pre-let rate [2] - The company delivered 11 projects totaling 264,000 sqm during H1 2025, achieving a 96.3% let rate [2] Land Acquisition and Development Potential - VGP acquired 633,000 sqm of development land, expanding into the UK and several other European countries [2] - The total secured landbank now stands at 9.7 million sqm, with a development potential exceeding 4 million sqm, estimated to generate over €256 million in rental value [2] Renewable Energy Initiatives - Gross renewable income surged by 71.5% year-over-year to €6.5 million, with total renewable energy capacity installed increasing from 143 MW to 177.3 MW [2] - Marketable production of renewable energy rose from 47 GWh to 70 GWh, reflecting a 49% year-over-year increase [2] Financial Stability and Outlook - The company has available liquidity of €0.9 billion and extended the maturity of outstanding financial indebtedness through bond issuances totaling €576 million [2] - VGP's EPRA NTA increased by 4.8% since December 2024 and by 11.5% year-over-year [2] - The company received an investment grade BBB- rating from Standards & Poor's with a stable outlook [2]

Schiphol, August 21, 2025 - Please click here to access all 1H 2025 results related documents. 1H 2025 Financial highlights 1H 2025 Capital highlights Strategic developments Review announced on relocating Aegon's legal domicile and head office to the United States Lard Friese, Aegon CEO, commented: "We generated strong commercial momentum across our key markets in the first half of 2025. In the United States, new life sales increased by 13% to USD 276 million, while World Financial Group (WFG) continued to ...

Strong second quarter for Kinepolis cinemas thanks to international blockbusters Regulated information 21 August 2025, 7.00 am CET After a weak start to the year due to a limited blockbuster offering, Kinepolis posted strong second-quarter results, driven by a robust international film lineup and an effective premiumisation strategy. The success of 'A Minecraft Movie', 'Lilo & Stitch' and 'Mission Impossible: The Final Reckoning', among others, boosted visitor numbers by 17.3% in the second quarter compared ...

Core Viewpoint - Molecular Partners AG has appointed Martin Steegmaier, Ph.D., as Chief Scientific Officer (CSO), effective October 1, 2025, to enhance its oncology drug development efforts, particularly in DARPin therapeutics [1][2]. Company Overview - Molecular Partners AG is a clinical-stage biotech company focused on developing DARPin therapeutics, which are custom-built protein drugs aimed at addressing medical challenges that other drug modalities cannot effectively tackle [6]. - The company has a pipeline that includes various programs in pre-clinical and clinical development, with a primary focus on oncology [6]. Leadership Appointment - Martin Steegmaier brings extensive experience in oncology drug development from previous roles at Roche, MorphoSys, Boehringer Ingelheim, and SOTIO Biotech, where he led the development of a broad pipeline of oncology programs [1][3][2]. - The CEO of Molecular Partners, Patrick Amstutz, expressed confidence that Steegmaier's expertise will significantly contribute to the company's research organization and the advancement of its targeted DARPin therapeutics [2]. Educational Background - Martin Steegmaier holds a Ph.D. in biochemistry from the University of Basel and an MBA from the Edinburgh Business School, which complements his extensive experience in the biotech and pharmaceutical sectors [4]. Future Directions - The company aims to innovate and advance its pipeline of targeted DARPin therapeutics, including Radio-DARPins and Switch-DARPins, which are designed for logic-gated immune cell activation [2][5].

Group 1 - The company, Vantage Drilling International Ltd., will host a conference call on August 28, 2025, at 10:00 AM Eastern Time to discuss its operating results for the second quarter of 2025 [1] - Earnings will be released before the conference call on the same day and will be available on the company's website [1] - Vantage is an offshore drilling contractor that primarily contracts drilling units and related services to oil and gas companies globally [4] Group 2 - The company provides management services for third-party-owned drilling units in addition to its primary business [4] - Contact information for the Chief Financial Officer, Rafael Blattner, is provided for further inquiries [5] - Instructions for accessing the conference call include a registration process and options for joining the call [6]

Core Viewpoint - DNO ASA reported strong second quarter results with significant increases in revenue and operating profit, driven by production growth and the recent acquisition of Sval Energi Group AS [1][12]. Financial Performance - Revenue increased by 37% to USD 258 million from the prior quarter [1][12]. - Operating profit surged by 206% to USD 86 million [1][12]. - Net profit showed a loss of USD 7 million, an improvement from a loss of USD 4 million in the previous quarter [12]. Production and Operations - Net production rose by 10% to 92,600 barrels of oil equivalent per day (boepd) [2][12]. - Production sources included 56,100 boepd from the Kurdistan region, 33,300 boepd from the North Sea, and 3,200 boepd from West Africa [2]. - Following the Sval acquisition, North Sea production is projected to reach 80,000-85,000 boepd in the second half of 2025 [2]. Strategic Focus - The company aims to enhance cash value for shareholders through increased dividends while managing expenditures [4]. - DNO plans to reduce debt levels and costs [4]. - The company is also focused on divesting low-return projects and acquiring higher-return assets [8]. Exploration and Development - DNO has made three commercial discoveries in four exploration wells this year, totaling net mean resources of 34 million barrels of oil equivalent (MMboe) [7]. - The company has six ongoing tieback developments expected to contribute approximately 25,000 boepd net by the end of 2029 [5]. Financing Activities - DNO issued a USD 400 million hybrid bond in June and repaid over USD 600 million in reserve-based lending facilities [10]. - The company entered into a North Sea gas offtake agreement and a related USD 500 million financing facility [10]. Dividend Announcement - The Board of Directors authorized a dividend payment of NOK 0.375 per share, representing a 20% increase from prior distributions [11].

Kojamo plc Stock Exchange Release, 21 August 2025 at 8.00 a.m. EEST Kojamo plc Half-Year Financial Report 1 January–30 June 2025 Strong increase in occupancy rate continued This is a summary of the January–June Half-Year Financial Report, which is in its entirety attached to this release and can be downloaded from the company's website at www.kojamo.fi/investors. Unless otherwise stated, the comparison figures in brackets refer to the corresponding period of the previous year. The figures in this Half-Year ...

Core Insights - The company has confirmed its financial guidance for 2025, narrowing organic revenue growth expectations to a range of -2% to +2% [8][12] - The Hearing division is expected to contribute organic revenue growth of 5% to 9%, but due to lower market growth assumptions, it is now anticipated to grow at the lower end of that range [5][4] - The Enterprise division is facing challenges due to market uncertainty, with expected organic revenue growth of -8% to 0% [6] - The Gaming division is also impacted by trade environment changes, with organic revenue growth now expected in the upper half of the range of -6% to +2% [7] Financial Performance - Group reported EBITA increased by 46% to DKK 546 million, with an EBITA margin of 13% [8] - Free cash flow excluding M&A was DKK 353 million, reflecting a positive earnings profile and working capital impact [8] - The Hearing division achieved 8% organic revenue growth, while the Enterprise division saw a decline of -7% [8][10] Market Conditions - The hearing aid market is projected to grow at 4-6% in volumes, driven by favorable demographic trends, but is expected to grow slower than its structural trend in 2025 [4] - The company is actively diversifying its manufacturing footprint and implementing price adjustments to mitigate impacts from the changing trade environment [6][9] - The overall impact of tariffs is expected to reduce the group EBITA margin by approximately -1% in 2025 [10]